Gastrointestinal stromal tumour
Last updated 14 Jul 2021
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
A gastrointestinal stromal tumour (GIST) is a type of tumour that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. This type of tumour is thought to grow from specialized cells found in the gastrointestinal tract called interstitial cells of Cajal (ICCs) or precursors to these cells. Affected individuals can develop one or more tumours. GISTs are usually found in adults between ages 40 and 70; rarely, children and young adults develop this type of tumour.
Video picks for Genetic conditionsVideo library
Description
A gastrointestinal stromal tumour (GIST) is a type of tumour that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. This type of tumour is thought to grow from specialized cells found in the gastrointestinal tract called interstitial cells of Cajal (ICCs) or precursors to these cells. Affected individuals can develop one or more tumours. GISTs are usually found in adults between ages 40 and 70; rarely, children and young adults develop this type of tumour.
Small tumours may cause no signs or symptoms. However, some people with GISTs may experience pain or swelling in the belly area (abdomen), nausea, vomiting, loss of appetite, or weight loss. Sometimes, tumours cause bleeding into the gastrointestinal tract, which may lead to low red blood cell counts (anaemia) and, consequently, weakness and tiredness. Bleeding into the intestines may cause black and tarry stools, and bleeding into the throat or stomach may cause vomiting of blood.
Affected individuals with no family history of GIST typically have only one tumour (called a sporadic GIST). People with a family history of GISTs (called familial GISTs) often have multiple tumours and additional signs or symptoms, including noncancerous overgrowth (hyperplasia) of other cells in the gastrointestinal tract and patches of dark skin on various areas of the body. Some affected individuals have a skin condition called urticaria pigmentosa (also known as maculopapular cutaneous mastocytosis), which is characterised by raised patches of brownish skin that sting or itch when touched.
A rare form of GIST, called succinate dehydrogenase (SDH)-deficient GIST, tends to occur in childhood or young adulthood and affects females more commonly than males. In this form, tumours are almost always in the stomach. Individuals with an SDH-deficient GIST have a high risk of developing other types of tumours, particularly noncancerous tumours in the nervous system called paragangliomas and noncancerous lung tumours called pulmonary chondromas. When GISTs occur in combination with paragangliomas, the condition is known as Carney-Stratakis syndrome; the combination of GISTs, paragangliomas, and pulmonary chondromas is known as Carney triad; and the combination of GISTs and pulmonary chondroma is known as incomplete Carney triad.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant; Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Gastrointestinal stromal neoplasm
Gastrointestinal stromal sarcoma
GIST
Patient picks for Genetic conditions

Cancer
Bowel cancer
Colon cancer and rectal cancer (also called colorectal cancer) are common in the UK. The colon and rectum are parts of your bowel. Most cases occur in people aged over 50. If bowel cancer is diagnosed at an early stage, there is a good chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. However, treatment can often slow the progress of the cancer.
by Dr Doug McKechnie, MRCGP

Tests and investigations
Faecal immunochemical test
The faecal immunochemical test helps to diagnose bleeding disorders of the gut (intestine).
by Dr Colin Tidy, MRCGP

Cancer
Pancreatic cancer - recognising the symptoms that can be easy to dismiss
Pancreatic cancer can hide behind seemingly ordinary symptoms, and is often mistaken for more common conditions - such as indigestion. Potential warning signs may go unnoticed, and can be easily overlooked indicators of something more serious. In the UK, twenty-nine people are newly diagnosed with the disease each day. But recognising the symptoms early, receiving a diagnosis, and getting medical treatment quickly can increase your chances of survival and recovery.
by Hannah Boynton-Forshaw

Cancer
Stomach cancer
Although stomach (gastric) cancer is common worldwide, it is not so common in the UK. Most cases occur in people over the age of 55. If stomach cancer is diagnosed at an early stage, there is a good chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. However, treatment can often slow the progress of the cancer.
by Dr Doug McKechnie, MRCGP

Cancer
Oesophageal cancer
Oesophageal cancer is cancer of the gullet (oesophagus). There are over 8,000 new cases diagnosed every year in the UK and two thirds of new diagnoses are in men.t is the 7th most common cause of cancer death in the UK and accounts for 5% of all cancer deaths. Most cases occur in people over the age of 55, although younger people are sometimes affected. Those diagnosed at an early stage have the best chance of a cure. The earliest symptom is often difficulty with swallowing (dysphagia).
by Dr Toni Hazell, FRCGP

Digestive health
Gastroenteritis
Gastroenteritis, also known as 'stomach-flu', is the inflammation of the stomach and intestines, caused by viruses, bacteria or other microbes. It causes symptoms such as diarrhoea, vomiting, and abdominal pain. Most cases are mild and improve on their own, however, dehydration can occur. This leaflet explains the causes, symptoms, treatment, and prevention of gastroenteritis.
by Dr Colin Tidy, MRCGP
Related patient information and medicines

Patient information leaflet
Bowel cancer
Colon cancer and rectal cancer (also called colorectal cancer) are common in the UK. The colon and rectum are parts of your bowel. However, treatment can often slow the progress of the cancer. What is bowel cancer? | Patient Explainers Colon cancer and rectal cancer (also called colorectal cancer) are common in the UK. The colon and rectum are.

Patient information leaflet
Faecal immunochemical test
The faecal immunochemical test helps to diagnose bleeding disorders of the gut (intestine). What is a faecal immunochemical test. Krishna Vakharia , 12th September 2023 The National Institute for Health and Care Excellence (NICE) has updated its guidance to use faecal immunochemical testing (FIT) to guide referral for suspected bowel cancer as an.

Patient information leaflet
Stomach cancer
About 5,000 people develop stomach cancer each year in the UK. Stomach cancer is more common in men than in women and tends to occur mainly in older people. Adenocarcinoma of the stomach In most cases, stomach cancer begins from a cell which is on... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence.

Patient information leaflet
Oesophageal cancer
Oesophageal cancer is cancer of the gullet (oesophagus). There are over 8,000 new cases diagnosed every year in the UK and two thirds of new diagnoses are in men.t is the 7th most common cause of cancer death in the UK and accounts for 5% of all cancer deaths. In general, the more advanced the cancer (the more... What is oesophageal cancer..

Patient information leaflet
Gastroenteritis
Gastroenteritis, also known as 'stomach-flu', is the inflammation of the stomach and intestines, caused by viruses, bacteria or other microbes. It causes symptoms such as diarrhoea, vomiting, and abdominal pain. This leaflet explains the causes, symptoms, treatment, and prevention of gastroenteritis. Key points Gastroenteriti... What is.

Patient information leaflet
Helicobacter pylori
Helicobacter pylori is a type of bacteria. It's commonly found in the stomach. Many people with Helicobacter pylori have no symptoms at all, but it can cause stomach irritation (gastritis) and stomach ulcers. What is Helicobacter pylori. Helicobacter pylori (commonly shorted to H. pylori) is a germ (bacterium). Pylori bacteria can infect the.
Further reading and references
- Gastrointestinal stromal tumour; MedlinePlus, National Library of Medicine.
- Agaram NP, Wong GC, Guo T, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer. 2008 Oct;47(10):853-9. doi: 10.1002/gcc.20589.
- Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003 Jan 31;299(5607):708-10. doi: 10.1126/science.1079666. Epub 2003 Jan 9.
- Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998 Jan 23;279(5350):577-80. doi: 10.1126/science.279.5350.577.
- Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003 Sep;125(3):660-7. doi: 10.1016/s0016-5085(03)01046-1.
- Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol. 2000 Nov;157(5):1581-5. doi: 10.1016/S0002-9440(10)64795-5.
- Oudijk L, Gaal J, Korpershoek E, van Nederveen FH, Kelly L, Schiavon G, Verweij J, Mathijssen RH, den Bakker MA, Oldenburg RA, van Loon RL, O'Sullivan MJ, de Krijger RR, Dinjens WN. SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors. Mod Pathol. 2013 Mar;26(3):456-63. doi: 10.1038/modpathol.2012.186. Epub 2012 Nov 23.
- Roskoski R Jr. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. Biochem Biophys Res Commun. 2005 Nov 11;337(1):1-13. doi: 10.1016/j.bbrc.2005.08.055.
- Wagner AJ, Remillard SP, Zhang YX, Doyle LA, George S, Hornick JL. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod Pathol. 2013 Feb;26(2):289-94. doi: 10.1038/modpathol.2012.153. Epub 2012 Sep 7.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

